Briefly, the anti-apoptosis effect in the liver of rats with NAFLD was mediated via the JNK signaling pathway and treated with a ceramide synthesis inhibitor. This evidence concerns the gene MAPK8 and metabolic dysfunction-associated steatotic liver disease.